5-Minute Clinical Consult

Hepatic Encephalopathy

Hepatic Encephalopathy was found in 5-Minute Clinical Consult which helps you diagnose, treat, and follow up on over 900 medical conditions seen in everyday practice.

To view this entire topic, please or purchase a subscription.

Explore 5-Minute Clinical Consult - view these FREE monographs:

5-Minute Clinical Consult

-- The first section of this topic is shown below --

Basics

Description

  • Reversible altered mental and neuromotor functioning associated with acute or chronic liver disease and/or portal systemic shunting of blood
  • The prominent features are confusion, impaired arousability, and a “flapping tremor” (asterixis).
  • System(s) affected: Gastrointestinal; Nervous
  • Synonym(s): Portosystemic encephalopathy; Hepatic coma; Liver coma

Epidemiology

Predominant sex: Male = Female (reflecting underlying liver disease)

Prevalence
  • Occurs in 1/3 of cirrhosis cases
  • Occurs in all cases of fulminant hepatic failure
  • Present in nearly 1/2 of patients who require transplantation
  • Parallels the age predominance of fulminant liver disease: Peaks in the 40s; cirrhosis peaks in the late 50s; may occur at any age

Risk Factors

In patients with underlying liver disease, precipitating factors include:
  • Infection (overt or occult, including spontaneous bacterial peritonitis)
  • GI hemorrhage
  • Use of sedative or opiate drugs
  • Fluid or electrolyte disturbance (Na+, K+, Mg2+, or other electrolyte depletion)
  • Transjugular intrahepatic portosystemic shunt (TIPS)

Genetics
  • Unknown
  • Conditions such as cystic fibrosis, α-1-antitrypsin deficiency, and Wilson disease can contribute to hepatic encephalopathy (HE).

General Prevention

  • Recognize early signs and seek prompt treatment.
  • Avoid nonessential medications, particularly opiates and sedatives.

Pathophysiology

  • Failure of liver to detoxify agents noxious to the CNS (e.g., ammonia, mercaptans, fatty acids)
  • Increased aromatic and reduced branched-chain amino acids in blood
  • These act as false neurotransmitters, possibly inter-acting with the γ-aminobutyric acid (GABA) receptor

Etiology

  • Shunting of intestinal blood through the severely diseased liver without the intervention of viable liver cells
  • Most common in long-standing cirrhosis of the liver with spontaneous shunting of intestinal blood through collateral vessels
  • Shunting of such blood through collateral circulation or surgically constructed portacaval shunts
  • TIPS, a widely used radiologically inserted shunt to lower portal pressure, produces HE.
  • Acute onset of HE: Search for risk factors.

Commonly Associated Conditions

  • Occurs rarely with portacaval shunt with normal liver function
  • May occur as a complication of acute fatty liver of pregnancy

-- To view the remaining sections of this topic, please or purchase a subscription --